▼ Safinamide (Xadago - Zambon S.p.A) is a monoamine-oxidase B (MAO-B) inhibitor 
licensed as add-on therapy for people with idiopathic Parkinson's disease who 
are experiencing motor fluctuations with levodopa.1 Currently there is no cure 
for Parkinson's disease and drugs are used to reduce motor symptoms and improve 
daily activities.2,3 Here, we review the evidence for this MAO-B inhibitor.